The antipruritic drug difelikefalin, a selective KOR agonist, showed an inhibitory effect on the inflammatory response and renal dysfunction in a rat model of I/R-induced AKI, with varying efficacy in terms of anti-inflammatory action among KOR agonists. This evidence concerns the gene OPRK1 and acute kidney injury.